Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG

Dreikorn, K.; Doerr, H.W.; Geursen, R.G.

Scandinavian Journal of Urology and Nephrology. Supplementum 92: 15-21

1985

ISSN/ISBN: 0300-8886
PMID: 3008312
Document Number: 258894
Infectious diseases are the most serious complications in immunosuppressed patients and the major cause of death in renal transplant recipients (23, 44). Besides bacterial, fungal and protozoan infections, viruses of the human herpes group (herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus) are known to be of major importance (21, 37). The most common and clinically relevant virus of this group is the cytomegalovirus (CMV).

Document emailed within 1 workday
Secure & encrypted payments

Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Harland, R.C.; Vernon, W.B.; Bunzendahl, H.; Thompson, J.K.; Lawrence, C.; Bollinger, R.R. 1994: Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients Transplantation Proceedings 26(2): 432-433
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Uber, L.; Cofer, J.; Baliga, P.; Rajagopalan, P.R. 1995: Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient Transplantation Proceedings 27(5 Suppl 1: 42-43
Baldwin, W.M.; van Es, A.; Valentijn, R.M.; van Gemert, G.W.; Daha, M.R.; Vanes, L.A. 1982: Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections Clinical and Experimental Immunology 50(3): 515-524
Razonable, R.R.; Paya, C.V. 2003: Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections Herpes: the Journal of the Ihmf 10(3): 60-65
Jankowski, M.; Gut, W.; Nawrocka, E.; Gradowska, L.; Roncewicz, Z.; Rowińska, D. 1982: Cytomegalovirus antibodies in renal transplant recipients Acta Microbiologica Polonica 31(3-4): 279-285
Moreno, J.; Montero, J.L.; Gavilán, F.; Costán, G.; Herrero, C.; Cárdenas, M.; Sánchez-Guijo, P.; Torre-Cisneros, J. 1999: Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(8): 382-385
Pollard, R.B.; Merigan, T.C. 1978: Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 241-245
Anteyi, E.A.; Liman, H.M.; Gbaji, A. 2003: Malaria prophylaxis in post renal transplant recipients in the tropics: is it necessary? Central African Journal of Medicine 49(5-6): 63-66
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Reina, J.; Alberto, C.; Ballesteros, F.; Munar, M.; Marí, M. 1999: Comparison between centrifugation and sedimentation prior to cultures in the isolation of cytomegalovirus in the urine of renal transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(2): 82-84
Siennicka, J.; Durlik, M.; Litwińska, B.; Chmura, A.; Lewandowska, D.; Lao, M.; Paczek, L.; Kańtoch, M. 1999: Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment Acta Microbiologica Polonica 48(1): 61-71
Lilleri, D.; Gerna, G.; Bruno, F.; Draghi, P.; Gabanti, E.; Fornara, C.; Meloni, F. 2013: Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients New Microbiologica 36(3): 267-277
Segondy, M.; Mourad, G.; Boumzebra, A.; Montes, B.; Leray, H. 1996: Comparison of viral culture, pp-65 antigenemia, and polymerase chain reaction for the detection of cytomegalovirus in blood specimens from renal transplant recipients Transplantation Proceedings 28(5): 2810
Morduchowicz, G.; Pitlik, S.D.; Shapira, Z.; Shmueli, D.; Yussim, A.; Djalovski, S.; Rosenfeld, J.B. 1985: Infections in renal transplant recipients in Israel Israel Journal of Medical Sciences 21(10): 791-797
Luo, W. 1991: Pulmonary infections in renal transplant recipients Zhonghua Yi Xue Za Zhi 71(5): 246-248; 18
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065
Chatterjee, S.N.; Gottlieb, L.; Berne, T.V. 1978: Fulminant pulmonary infections in renal transplant recipients Surgery Gynecology and Obstetrics 147(4): 583-587
Carmellini, M.; Romagnoli, J.; Pietrabissa, A.; Di Stefano, R.; Oleggini, M.; Rindi, P.; Rizzo, G.; Mosca, F. 1994: Evaluation of infections in renal transplant recipients treated with cyclosporine Transplantation Proceedings 26(5): 2658-2659